WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4501 Infant (under 12 months) mortality rate: 492
GDP / capita (US$): 1'6301 Child (under 5 years) mortality rate: 732

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 1'909  1'849  1'791  1'735  1'681  1'229  917  604 
Births 81  79  77  75  73  56  43  31 
Surviving infants 77  75  73  71  69  52  40  28 
Pop. less than 5 years 349  339  328  318  309  231  175  118 
Pop. less than 15 years 875  849  824  798  773  564  423  272 
Female 15-49 years 454  440  426  413  401  293  211  143 

Number of reported case

(Click for retrospective incidence data for Gambia (the))
Diphtheria
Japanese encephalitis
Measles 336  284 
Mumps
Pertussis 157 
Polio*
Rubella 35  66  39  42  14 
Rubella (CRS)
Tetanus (neonatal) 44 
Tetanus (total)** 567 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Gambia (the))
Vaccine year result method % card seen                                                
BCG 2011  99  EPI   99  96  96  95  90  96  97  98  85 
DTP1 2011  97  EPI   99  98  98  99  99  95  89  98  89 
DTP3 2011  95  EPI   99  96  98  98  96  95  74  92 
DTP4         
IPV1         
HepB_BD          96  96  95  90  95  87 
HepB3 2011  95  EPI   99  96  98  98  96  95  87  93 
Hib3 2011  95  EPI   99  96  98  98  96  95  74 
JapEnc         
MCV1          96  94  93  91  89  92  86  69 
MCV2          73  78  56 
PCV1          98  98  99  99  95 
PCV3 2011  93  EPI   99  96  98  98  93  94 
Pol3 2011  94  EPI   99  97  98  98  95  96  92  94  53 
Rota1          96  90 
Rota_last          92  90 
Rubella1         
TT2plus 2011  92  EPI   99  60  78  71  61  88  90  73 
PAB         
VAD1          54 
YFV 2011  90  EPI   99  96  94  93  91  89  91 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Gambia (the))
BCG 96  98  98  90  92  99  98  85 
DTP1 98  99  99  99  99  97  98  89 
DTP3 96  97  98  96  97  80  92  63 
HepB3 96  97  98  96  97  91 
HepB_BD 96  93  97  90  93  95 
Hib3 96  97  98  96  97  90 
MCV1 96  96  95  91  92  89  86  69 
MCV2 73  53  56 
PAB 92  82  92  91  91  92  85 
PCV3 96  96  98  95  99 
Pol3 97  96  98  95  97  84  94  53 
Rota_last 92 
YFV 96  97  95  91  92  85 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18-24 months; Yes Booster
DTwPHibHepB 2, 3, 4 months; Yes
HPV 9-13 years; +6 months; No
HepB birth; Yes
IPV Yes From April 2015
MR 9 months; Yes From March 2016
Measles 9, 18 months; Yes
OPV birth; 2, 3, 4, 9, 18 months; Yes
Pneumo_conj 2, 3, 4 months; Yes
Rotavirus 2, 3, 4 months; Yes
TT 1st contact; +1, +6 months; +1, +2 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  83 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 29  83  50  67  33  67  17 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 35    31  10    20  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.